Importance and relevance of pulmonary symptoms among patients receiving second- and third-line treatment for advanced non-small-cell lung cancer: Support for the content validity of the 4-item Pulmonary Symptom Index

Clinical Lung Cancer

Volumn 14, Issue 3, 2013, Pages 245-253

  Magasi, Susan ^a   Mallick, Rajiv ^b   Kaiser, Karen ^a   Patel, Jyoti D ^a   Lad, Thomas ^c   Johnson, Melissa L ^a   Kaplan, Edward H ^d,e   Cella, David ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b DAIICHI SANKYO INC   (United States)

^c Department of Medical Oncology   (United States)

^d RUSH MEDICAL COLLEGE   (United States)

^e Hematology Oncology of the North Shore   (United States)

Author keywords

Cough; Dyspnea; Pain; Patient centered; Quality of life

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CHEST TIGHTNESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COMORBIDITY; CONTENT VALIDITY; CONTROLLED STUDY; COUGHING; DYSPNEA; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; PULMONARY SYMPTOM INDEX; SEMI STRUCTURED INTERVIEW; SYMPTOM ASSESSMENT; SYSTEMIC THERAPY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CHEST PAIN; COUGH; DYSPNEA; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATIENT ACUITY; QUALITY OF LIFE; SALVAGE THERAPY;

EID: 84879931223     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2012.07.001     Document Type: Article

References (60)

1. American Cancer Society Cancer facts and figures 2012 2012 American Cancer Society Atlanta, GA
2. R. Siegel, D. Naishadham, A. Jemal Cancer statistics CA Cancer J Clin 2012 2012 10 29
3. American Cancer Society Lung cancer (non-small cell) 2012 American Cancer Society Atlanta, GA
4. W.A. Fry, J.L. Phillips, H.R. Menck Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report Cancer 86 1999 1867 1876
5. C.C. Earle, W.K. Evans Management issues for stage IV non-small cell lung cancer Cancer Control 4 1997 307 316
6. P.J. Hollen, R.J. Gralla, M.G. Kris Quality of life assessment in individuals with lung cancer: testing the lung cancer symptom scale (LCSS) Eur J Cancer 29A Suppl 1 1993 S51 S58
7. M.K. Soni, D. Cella, G.A. Masters The validity and clinical utility of symptom monitoring in advanced lung cancer: a literature review Clin Lung Cancer 4 2002 153 160
8. M.E. Cooley Symptoms in adults with lung cancer A systematic research review J Pain Symptom Manage 02 2000 137 153
9. L. Sarna, M.L. Brecht Dimensions of symptom distress in women with advanced lung cancer: afactor analysis Heart Lung 26 1997 23 30
10. A. Vainio, A. Auvinen Prevalence of symptoms among patients with advanced cancer: an international collaborative study Symptom Prevalence Group J Pain Symptom Manage 12 1996 3 10
11. S. Lutz, R. Norrell, C. Bertucio Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: A prospective study using the lung cancer symptom scale in a community hospital J Palliat Med 4 2001 157 165
12. L. Sarna, A.M. Lindsey, H. Dean Nutritional intake, weight change, symptom distress, and functional status over time in adults with lung cancer Oncol Nurs Forum 20 1993 481 489
13. P.M. Silberfarb, P.J. Hauri, T.E. Oxman Insomnia in cancer patients Soc Sci Med 20 1985 849 850
14. L. Sarna Correlates of symptom distress in women with lung cancer Cancer Pract 1 1993 21 28
15. M. Larsson, L. Ljung, B.B. Johansson Health-related quality of life in advanced non-small cell lung cancer: correlates and comparisons to normative data Eur J Cancer Care (Engl) 21 2012 1365 2354
16. S. Yount, J. Beaumont, S. Rosenbloom A brief symptom index for advanced lung cancer Clin Lung Cancer 13 2012 14 23
17. Z. Butt, S.K. Rosenbloom, A.P. Abernethy Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy J Natl Compr Canc Netw 6 2008 448 455
18. D.J. Dudgeon, L. Kristjanson, J.A. Sloan Dyspnea in cancer patients: prevalence and associated factors J Pain Symptom Manage 21 2001 95 102
19. P. Hopwood, R.J. Stephens Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data J Clin Oncol 18 2000 893 903
20. L.F. Degner, J.A. Sloan Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer J Pain Symptom Manage 10 1995 423 431
21. V.T. Chang, S.S. Hwang, M. Feuerman Symptom and quality of life survey of medical oncology patients at a Veterans Affairs Medical Center: a role for symptom assessment Cancer 88 2000 1175 1183
22. S. Donnelly, D. Walsh, L. Rybicki The symptoms of advanced cancer: identification of clinical and research priorities by assessment of prevalence and severity J Palliat Care 11 1995 27 32
23. S. Grond, D. Zech, C. Diefenbach Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic J Pain Symptom Manage 9 1994 372 382
24. R. McCorkle, J. Quint-Benoliel Symptom distress, current concerns and mood disturbance after diagnosis of life-threatening disease Soc Sci Med 17 1983 431 438
25. M.E. Cooley, T.H. Short, H.J. Moriarty Symptom prevalence, distress, and change over time in adults receiving treatment for lung cancer Psychooncology 12 2003 694 708
26. J.S. Temel, W.F. Pirl, T.J. Lynch Comprehensive symptom management in patients with advanced-stage non-small-cell lung cancer Clin Lung Cancer 7 2006 241 249
27. P. Hopwood, R.J. Stephens Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment The Medical Research Council (MRC) lung cancer working party Br J Cancer 71 1995 633 636
28. S. Lutz, R. Norrell, C. Bertucio Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: a prospective study using the lung cancer symptom scale in a community hospital J Palliat Med 4 2001 157 165
29. R.K. Portenoy, H.T. Thaler, A.B. Kornblith The memorial symptom assessment scale: an instrument for the evaluation of symptom prevalence, characteristics and distress Eur J Cancer 30A 1994 1326 1336
30. A.D. Weisman, J.W. Worden Coping and vulnerability in cancer patients: final report 1976 National Cancer Institute Bethesda, MD
31. J. McCannon, J. Temel Comprehensive management of respiratory symptoms in patients with advanced lung cancer J Support Oncol 10 2012 1 9
32. D.C. Currow, J. Smith, P.M. Davidson Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study J Pain Symptom Manage 39 2010 680 690
33. G. Fan, S. Hadi, E. Chow Symptom clusters in patients with advanced-stage cancer referred for palliative radiation therapy in an outpatient setting Support Cancer Ther 4 2007 157 162
34. A. Jiménez, R. Madero, A. Alonso Symptom clusters in advanced cancer J Pain Symptom Manage 42 2011 24 31
35. J.B. Wilson, P.D. Cleary Linking clinical variables with health-related quality of life A conceptual model of health outcomes JAMA 273 1995 59 65
36. S. Kaasa, A. Mastekaasa, E. Thorud Toxicity, physical function and everyday activity reported by patients with inoperable non-small cell lung cancer in a randomized trial (chemotherapy versus radiotherapy) Acta Oncol 27 1988 343 349
37. D.F. Cella, B. Orofiamma, J.C. Holland The relationship of psychological distress, extent of disease, and performance status in patients with lung cancer Cancer 60 1987 1661 1667
38. L. Sarna Functional status in women with lung cancer Cancer Nurs 17 1994 87 93
39. I.T. Lennes, T.J. Lynch Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer Clin Lung Cancer 10 2009 341 346
40. R. Feld, U. Sagman, M. LeBlanc Staging and prognostic factors for small cell lung cancer. Lung Cancer: Principles and Practice 2000 Lippincott Williams & Wilkins Philadelphia, PA 612 627
41. U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims, 2009 Accessed: September 13, 2012 http://purl.access.gpo.gov/GPO/LPS113413
42. D. Cella, D. Eton, T.A. Hensing Relationship between symptom change, objective tumor measurements, and performance status during chemotherapy for advanced lung cancer Clin Lung Cancer 9 2008 51 58
43. M. Rothman, L. Burke, P. Erickson Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report Value Health 12 2009 1075 1083
44. G.J. Wan, M.A. Counte, D.F. Cella The impact of socio-cultural and clinical factors on health-related quality of life reports among Hispanic and African-American cancer patients J Outcome Meas 3 1999 200 215
45. E.A. Hahn, D. Rao, D. Cella Comparability of interview- and self-administration of the functional assessment of cancer therapy-general (FACT-G) in English- and Spanish-speaking ambulatory cancer patients Med Care 46 2008 423 431
46. D. Cella, E.A. Hahn, K. Dineen Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening Qual Life Res 11 2002 207 221
47. P. Bonomi, K. Kim, D. Fairclough Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial J Clin Oncol 18 2000 623 631 2
48. D. Cella, D.T. Eton, D.L. Fairclough What is a clinically meaningful change on the functional assessment of cancer therapy-lung (FACT-L) questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) study 5592 J Clin Epidemiol 55 2002 285 295
49. D.L. Patrick, L.B. Burke, C.J. Gwaltney Content validity - establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2 - assessing respondent understanding Value Health 14 2011 978 988
50. J. Nunnally Psychometric theory 1978 McGraw-Hill New York, NY
51. K.E. Lasch, P. Marquis, M. Vigneux PRO development: rigorous qualitative research as the crucial foundation Qual Life Res 19 2010 1087 1096
52. S. Magasi, G. Ryan, D. Revicki Content validity of patient-reported outcome measures: perspectives from a PROMIS meeting Qual Life Res 21 2012 739 746
53. M. Brod, L.E. Tesler, T.L. Christensen Qualitative research and content validity: developing best practices based on science and experience Qual Life Res 18 2009 1263 1278
54. K. Charmaz Constructing grounded theory: a practical guide though qualitative analysis 2006 Sage Publications Washington, DC
55. M.L. Janssen-Heijnen, R.M. Schipper, P.P. Razenberg Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study Lung Cancer 21 1998 105 113
56. C.M. Booth, F.A. Shepherd, Y. Peng Adoption of adjuvant chemotherapy for non-small-cell lung cancer: a population-based outcomes study J Clin Oncol 28 2010 3472 3478
57. F.A. Shepherd, J. Rodrigues Pereira, T. Ciuleanu Erlotinib in previously treated non-small-cell lung cancer N Engl J Med 353 2005 123 132
58. S.E. Embretson, S.P. Reise Item response theory for psychologists 2000 Lawrence Erlbaum Associates Mahwah, NJ
59. M.T. Claessens, J. Lynn, Z. Zhong Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments J Am Geriatr Soc 48 5 suppl 2000 S146 S153
60. National Comprehensive Cancer Network Practice guidelines in oncology: non-small cell lung cancer http://www.nccn.org/professionals/physician-gls/f- guidelines.asp 2011 Accessed: September 13, 2012